Nuclear localization of active matrix metalloproteinase-2 in cigarette smoke-exposed apoptotic endothelial cells

Experimental Lung Research

Volumn 35, Issue 1, 2009, Pages 59-75

  Ruta, Aldonyte ^a   Mark, Brantly ^a   Edward, Block ^a,b   Jawaharlal, Patel ^a,b   Jianliang, Zhang ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Cigarette smoke; Lung endothelium; Matrix metalloproteases; Nuclear matrix

Indexed keywords

CIGARETTE SMOKE; GELATIN; GELATINASE A; LIPOCORTIN 5; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL NUCLEUS MATRIX; CIGARETTE SMOKING; CONTROLLED STUDY; CYTOSOL; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME SUBSTRATE; LUNG ALVEOLUS CELL; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PULMONARY ARTERY; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; ANNEXIN A5; APOPTOSIS; CELL NUCLEUS; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; MATRIX METALLOPROTEINASE 2; POLY(ADP-RIBOSE) POLYMERASES; PULMONARY ARTERY; SMOKE; SMOKING; SWINE;

EID: 60749132264     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.1080/01902140802406059     Document Type: Article

References (34)

1. Thorin E, Shreeve SM: Heterogeneity of vascular endothelial cells in normal and disease states. Pharmacol Ther. 1998;78:155-166.
2. Nordskog B, Blixt A, Morgan W, Fields W, Hellmann G: Matrix-degrading and pro-inflammatory changes in human vascular endothelial cells exposed to cigarette smoke condensate. Cardiovasc Toxicol. 2003;3:101-117.
3. Ning W, Dong Y, Sun J, Li C, Matthay MA, Feghali-Bostwick CA, Choi AMK: Cigarette smoke stimulates matrix metalloproteinase-2 activity via EGR-1 in human lung fibroblasts. Am J Respir Cell Mol Biol. 2007;36:480-490.
4. Wright JL, Tai H, Wang R, Wang X, Churg A: Cigarette smoke upregulates pulmonary vascular matrix metalloproteinases via TNF-α signaling. Am J Physiol Lung Cell Mol Physiol. 2007;292:L125-L133.
5. Hummel V, Kallmann B, Wagner S, Fuller T, Bayas A, Tonn J, Benveniste E, Toyka K, Rieckmann P: Production of MMPs in human cerebral endothelial cells and their role in shedding adhesion molecules. J Neuropathol Exp Neurol. 2001;60:320-327.
6. Wu WB, Huang TF: Activation of MMP-2, cleavage of matrix proteins, and adherens junctions during a snake venom metalloproteinase-induced endothelial cell apoptosis. Exp Cell Res. 2003;288:143-157.
7. Warren MC, Bump EA, Medeiros D, Braunhut SJ: Oxidative stress-induced apoptosis of endothelial cells. Free Radic Biol Med. 2000;29:537-547.
8. Kuzuya M, Satake S, Ramos MA, Kanda S, Koike T, Yoshino K, Ikeda S, Iguchi A: Induction of apoptotic cell death in vascular endothelial cells cultured in three-dimensional collagen lattice. Exp Cell Res. 1999;248:498-508.
9. Yang H, Majno P, Morel P, Toso C, Triponez F, Oberholzer J, Mentha G, Lou J: Prostaglandin E1 protects human liver sinusoidal endothelial cell from apoptosis induced by hypoxia reoxygenation. Microvasc Res. 2002;64:94-103.
10. Kwan JA, Schulze CJ, Wang W, Leon H, Sariahmetoglu M, Sung M, Sawicka J, Sims DE, Sawicki G, Schulz R: Matrix metalloproteinase-2 (MMP-2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (ADP-ribose) polymerase (PARP) in vitro. FASEB J. 2004;18:690-692.
11. McCawley LJ, Matrisian LM: Matrix metalloproteinases: they're not just for matrix anymore! Curr Opin Cell Biol. 2001;13:534-540.
12. Satoh MS, Lindahl T: Role of poly(ADP-ribose) formation in DNA repair. Nature. 1992;356:356-358.
13. Paquette B, Bisson M, Therriault H, Lemay R, Pare M, Banville P, Cantin AM: Activation of matrix metalloproteinase-2 and -9 by 2- and 4-hydroxyestradiol. J Steroid Biochem Mol Biol. 2003;87:65-73.
14. Gu Z, Kaul M, Yan B, Kridel SJ, Cui J, Strongin A, Smith JW, Liddington RC, Lipton SA: S-Nitrosylation of matrix metalloproteinases: Signaling pathway to neuronal cell death. Science. 2002;297:1186-1190.
15. Strongin AY, Marmer BL, Grant GA, Goldberg GI: Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2. J Biol Chem. 1993;268:14033-14039.
16. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M: A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature. 1994;370:61-65.
17. Morgunova E, Tuuttila A, Bergmann U, Isupov M, Lindqvist Y, Schneider G, Tryggvason K: Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed. Science. 1999;284:1667-1670.
18. César Neto JB, de Souza AP, Barbieri D, Moreno H Jr, Sallum EA, Nociti FH Jr: Matrix metalloproteinase-2 may be involved with increased bone loss associated with experimental periodontitis and smoking: a study in rats. J Periodontol. 2004;75:995-1000.
19. Seagrave J, Barr E, March T, Nikula K: Effects of cigarette smoke exposure and cessation on inflammatory cells and matrix metalloproteinase activity in mice. Exp Lung Res. 2004;30:1-15.
20. Morimoto Y, Tsuda T, Nakamura H, Hori H, Yamato H, Nagata N, Higashi T, Kido M, Tanaka I: Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases and extracellular matrix mRNA following exposure to mineral fibers and cigarette smoke in vivo. Environ Health Perspect. 1997;105:1247-1251.
21. Li W, Xu Y, Zhang Z: Activity of matrix metalloproteinase in airway epithelial cells of COPD. J Huazhong Univ Sci Technolog Med Sci. 2005;25:151-154.
22. Galis ZS, Sukhova GK, Libby P: Microscopic localization of active proteases by in situ zymography: detection of matrix metalloproteinase activity in vascular tissue. FASEB J. 1995;9:974-980.
23. Dominaitiene R, Lindgren S, Janciauskiene S: Effects of differently oxidized LDL on the expression of pro-inflammatory molecules in human monocytes in vitro. In Vitro Mol Toxicol. 2001;14:83-97.
24. Johnson JL, Baker AH, Oka K, Chan L, Newby AC, Jackson CL, George SJ: Suppression of atherosclerotic plaque progression and instability by tissue inhibitor of metalloproteinase-2: involvement of macrophage migration and apoptosis. Circulation. 2006;113:2435-2444.
25. Soldani C, Bottone MG, Pellicciari C, Scovassi AI: Two-color fluorescence detection of poly (ADP ribose) polymerase-1 (PARP-1) cleavage and DNA strand breaks in etoposide-induced apoptotic cells. Eur J Histochem. 2001;45:389-392.
26. Hembry RM, Murphy G, Reynolds JJ: Immunolocalization of tissue inhibitor of metalloproteinases (TIMP) in human cells. Characterization and use of a specific antiserum. J Cell Sci. 1985;73:105-119.
27. Egeblad M, Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002;2:161-174.
28. Voelkel NF, Cool CD: Pulmonary vascular involvement in chronic obstructive pulmonary disease. Eur Respir J. 2003;22:28s-32s.
29. Bombeli T, Karsan A, Tait J, Harlan J: Apoptotic vascular endothelial cells become procoagulant. Blood. 1997;89:2429-2442.
30. Choy J, Granville D, Hunt D, McManus B: Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis. J Mol Cell Cardiol. 2001;33:1673-1690.
31. Lockshin R, Zakeri Z: Caspase-independent cell death? Oncogene. 2004;23:2766-2773.
32. Kuo WH, Chen JH, Lin HH, Chen BC, Hsu JD, Wang CJ: Induction of apoptosis in the lung tissue from rats exposed to cigarette smoke involves p38/JNK MAPK pathway. Chem Biol Interact. 2005;155:31-42.
33. Mannello F, Gazzanelli G: Tissue inhibitors of metalloproteinases and programmed cell death: conundrums, controversies and potential implications. Apoptosis. 2001;6:479-482.
34. Boya P, Andreau K, Poncet D, Zamzami N, Perfettini J, Metivier D, Ojcius D, Jaattela M, Kroemer G: Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion. J Exp Med. 2003;197:1323-1334.